STOCK TITAN
  1. Home
  2. Financials
  3. ATRA
  4. Revenue

Atara Biotherapeutics, Inc (ATRA) Revenue by Year

ATRA

Atara Biotherapeutics, Inc generated $120.8M in revenue in fiscal year 2025. This represents a decrease of 6.3% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $6.2M in revenue. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters Atara Biotherapeutics, Inc has filed alongside them.

FY2025 annual
Revenue $120.8M
YoY -6.3%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ATRA Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-K
Revenue$6.2M$120.8M-6.3%$128.9M+1404.0%$8.6M-86.5%$63.6MN/AN/AN/AN/AN/AN/AN/AN/AN/A

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

ATRA Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Revenue$630K-96.4%$516K-99.5%$1.6M-95.1%$3.5M-91.4%$17.6M-38.6%$98.1M+258.8%$32.8M+670.3%$40.2M+1779.8%$28.6M+2892.7%$27.4M+2131.4%$4.3M+1824.0%$2.1M-52.1%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Atara Biotherapeutics, Inc financials

Frequently Asked Questions

What was Atara Biotherapeutics, Inc's revenue in fiscal year 2025?

Atara Biotherapeutics, Inc generated $120.8M in revenue in fiscal year 2025.

How fast is Atara Biotherapeutics, Inc's revenue growing?

Atara Biotherapeutics, Inc (ATRA) revenue fell by 6.3% year over year, from $128.9M to $120.8M in fiscal year 2025.

What is Atara Biotherapeutics, Inc's revenue over the last twelve months?

Atara Biotherapeutics, Inc (ATRA) reported $6.2M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Atara Biotherapeutics, Inc (ATRA) reported $630K in revenue in Q2 2026. This represents a decrease of 96.4% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Atara Biotherapeutics, Inc (ATRA) reported on that line in every period on record.